Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
9.23%
GROSS MARGIN AVG 15Y
7.85%
GROSS MARGIN AVG 20Y
6.46%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Enveric Biosciences, Inc.
Market Cap
$6.76M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.74M
Gross Margin
-291.27%
TTM Avg
-237.54%
3Y Avg
-120.88%
5Y Avg
-89.07%
Market Cap
$6.72M
Gross Margin
80.62%
TTM Avg
90.31%
3Y Avg
-419.28%
5Y Avg
-4158.68%
Market Cap
$6.88M
Gross Margin
64.28%
TTM Avg
69.38%
3Y Avg
65.33%
5Y Avg
71.21%
Market Cap
$7.03M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
4.26%
5Y Avg
4.26%
Market Cap
$6.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.31M
Gross Margin
14.92%
TTM Avg
28.44%
3Y Avg
28.69%
5Y Avg
27.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -291.27% | -237.54% | -120.88% | -89.07% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | 80.62% | 90.31% | -419.28% | -4158.68% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | 64.28% | 69.38% | 65.33% | 71.21% |
| KALA BIO, Inc. (KALA)vs › | $7.01M | 0.00% | 0.00% | 8.55% | 24.65% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | 0.00% | 0.00% | 4.26% | 4.26% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | 8.09% | 8.76% | 9.29% | 9.67% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 14.92% | 28.44% | 28.69% | 27.44% |
| Femasys Inc. (FEMY)vs › | $6.10M | 61.96% | 64.25% | 64.10% | 65.91% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 278.79% |
| 2020-09-30 | 22.25% |
| 2020-06-30 | 22.02% |
| 2020-03-31 | 19.59% |
| 2019-12-31 | 19.08% |
| 2019-09-30 | 20.76% |
| 2019-06-30 | 21.63% |
| 2019-03-31 | 20.03% |
| 2018-12-31 | 18.53% |
| 2018-09-30 | 22.18% |
| 2018-06-30 | 21.57% |
| 2018-03-31 | 21.18% |
| 2017-12-31 | 17.81% |
| 2017-09-30 | 20.46% |
| 2017-06-30 | 19.01% |
| 2017-03-31 | 26.75% |
| 2016-12-31 | 16.69% |
| 2016-09-30 | 16.87% |
| 2016-06-30 | 22.69% |
| 2016-03-31 | 44.88% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 32.26% |
| 2015-06-30 | 25.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 208.43% |
| 2007-09-30 | 98.46% |
| 2007-06-30 | 91.32% |
| 2007-03-31 | 91.24% |
| 2006-12-31 | 135.16% |
| 2006-09-30 | 90.00% |
| 2006-06-30 | 90.00% |
| 2006-03-31 | 89.86% |
| 2005-12-31 | 89.70% |
| 2005-09-30 | 95.29% |
| 2005-06-30 | 90.00% |
| 2005-03-31 | 89.80% |
| 2004-12-31 | 89.87% |
| 2004-09-30 | 87.28% |
| 2004-06-30 | 92.28% |
| 2004-03-31 | 90.04% |
| 2003-12-31 | 91.64% |
| 2003-09-30 | 89.70% |
| 2003-06-30 | 91.03% |
| 2003-03-31 | 89.19% |
| 2002-12-31 | 94.69% |
| 2002-09-30 | 92.10% |
